LGND

Ligand Pharmaceuticals Incorporated - Common Stock (LGND)

About Ligand Pharmaceuticals Incorporated - Common Stock (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high

$197.00

Daily low

$189.17

Price at open

$194.61

52 Week High

$212.49

52 Week Low

$93.58

Market cap

3.8B

Dividend yield

0.00%

Volume

272,766

Avg. volume

246,773

P/E ratio

92.27

Ligand Pharmaceuticals Incorporated - Common Stock News